N
4.92
-1.08 (-18.02%)
前收盘价格 | 6.00 |
收盘价格 | 5.67 |
成交量 | 7,776,507 |
平均成交量 (3个月) | 6,383,984 |
市值 | 1,067,566,464 |
预期市盈率 (P/E Forward) | 16.00 |
价格/销量 (P/S) | 1.32 |
股市价格/股市净资产 (P/B) | 0.450 |
52周波幅 | |
利润日期 | 28 Jul 2025 - 1 Aug 2025 |
营业毛利率 | -53.56% |
营业利益率 (TTM) | 2.45% |
稀释每股收益 (EPS TTM) | -2.23 |
季度收入增长率 (YOY) | -3.40% |
总债务/股东权益 (D/E MRQ) | 33.61% |
流动比率 (MRQ) | 3.91 |
营业现金流 (OCF TTM) | 68.45 M |
杠杆自由现金流 (LFCF TTM) | 1.26 M |
资产报酬率 (ROA TTM) | 0.59% |
股东权益报酬率 (ROE TTM) | -16.71% |
市场趋势
短期 | 中期 | ||
行业 | Diagnostics & Research (US) | 看跌 | 看跌 |
Diagnostics & Research (全球的) | 看跌 | 看跌 | |
股票 | Neogen Corporation | 看跌 | 看跌 |
AIStockmoo 评分
1.5
分析师共识 | 1.0 |
内部交易活动 | 3.0 |
价格波动 | 0.5 |
技术平均移动指标 | 3.5 |
技术振荡指标 | -0.5 |
平均 | 1.50 |
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries. |
|
部门 | Healthcare |
行业 | Diagnostics & Research |
投资方式 | Small Core |
内部持股比例 | 0.38% |
机构持股比例 | 128.86% |
52周波幅 | ||
目标价格波幅 | ||
高 | 13.00 (Guggenheim, 164.29%) | 购买 |
中 | 9.00 (82.97%) | |
低 | 5.00 (Piper Sandler, 1.65%) | 保留 |
平均值 | 9.00 (82.97%) | |
总计 | 1 购买, 1 保留 | |
平均价格@调整类型 | 5.19 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
Piper Sandler | 22 Apr 2025 | 5.00 (1.65%) | 保留 | 4.75 |
14 Apr 2025 | 6.50 (32.15%) | 保留 | 5.40 | |
Guggenheim | 10 Apr 2025 | 13.00 (164.29%) | 购买 | 5.63 |
名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
---|---|---|---|---|
MOYLAN JOHN PATRICK | 5.69 | - | 26,362 | 150,000 |
NAEMURA DAVID H. | 5.69 | - | 52,724 | 300,000 |
ROCKLIN AMY M | 5.69 | - | 43,585 | 247,999 |
WAINER ANDREA F | 5.69 | - | 6,090 | 34,652 |
累积净数量 | 128,761 | |||
累积净值 ($) | 732,650 | |||
累积平均购买 ($) | 5.69 | |||
累积平均卖出 ($) | - |
名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
---|---|---|---|---|---|---|
MOYLAN JOHN PATRICK | 职员 | 02 Jun 2025 | 获得 (+) | 26,362 | 5.69 | 150,000 |
ROCKLIN AMY M | 职员 | 02 Jun 2025 | 获得 (+) | 43,585 | 5.69 | 247,999 |
NAEMURA DAVID H. | 职员 | 02 Jun 2025 | 获得 (+) | 52,724 | 5.69 | 300,000 |
WAINER ANDREA F | 董事 | 02 Jun 2025 | 获得 (+) | 6,090 | 5.69 | 34,652 |
日期 | 类型 | 细节 |
---|---|---|
05 Jun 2025 | 公告 | Neogen Launches Second Edition Environmental Monitoring Handbook to Elevate Food Safety Practices |
21 May 2025 | 公告 | Neogen® to Participate in the 45th Annual William Blair Growth Stock Conference |
13 May 2025 | 公告 | Neogen Announces Board Transition with Appointment of Andrea Wainer and Retirement of James P. Tobin |
21 Apr 2025 | 公告 | Neogen Announces Sale of Cleaners & Disinfectants Business |
09 Apr 2025 | 公告 | Neogen® Announces CEO Transition |
09 Apr 2025 | 公告 | Neogen Announces Third-Quarter 2025 Results |
07 Apr 2025 | 公告 | Neogen® Announces Refinancing of Term Loan and Revolving Credit Facility |
20 Mar 2025 | 公告 | Neogen Announces Third-Quarter Earnings Release Date |
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合